JW Pharmaceutical Co., Ltd. Preferred Stock logo

JW Pharmaceutical Co., Ltd. Preferred Stock (001065)

Market Closed
10 Aug, 06:30
KRX SM KRX SM
21,550. 00
+300
+1.4118%
667.56B Market Cap
- P/E Ratio
1,900% Div Yield
193 Volume
- Eps
21,250
Previous Close
Add Transaction
Day Range
21,300 21,850
Year Range
19,710 30,300
Want to track 001065 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

001065 closed today higher at ₩21,550, an increase of 1.4118% from yesterday's close, completing a monthly increase of 7.75% or ₩1,550. Over the past 12 months, 001065 stock lost -27.4411%.
001065 is not paying dividends to its shareholders.
The last earnings report, released on May 05, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
JW Pharmaceutical Co., Ltd. Preferred Stock has completed 19 stock splits, with the recent split occurring on Dec 27, 2023.
The company's stock is traded on one exchange.

001065 Chart

People also search for

Hyundai Motor Co.
408,000
+3.1606%
Hyundai Motor Co. Ltd.
193,200
+0.2075%
Hyundai Motor Co. Ltd. Preferred
197,500
0%
Hyundai Motor Co., Ltd. Preferred
201,500
+0.4988%
Kia Corporation
135,500
+0.4448%

JW Pharmaceutical Co., Ltd. Preferred Stock (001065) FAQ

What is the stock price today?

The current price is ₩21,550.00.

On which exchange is it traded?

JW Pharmaceutical Co., Ltd. Preferred Stock is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 001065.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1,900%.

What is its market cap?

As of today, the market cap is 667.56B.

Has JW Pharmaceutical Co., Ltd. Preferred Stock ever had a stock split?

JW Pharmaceutical Co., Ltd. Preferred Stock had 19 splits and the recent split was on Dec 27, 2023.

JW Pharmaceutical Co., Ltd. Preferred Stock Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Young-Sub Shin CEO
KRX SM Exchange
KR7001061001 ISIN
KR Country
1,048 Employees
31 Mar 2026 Last Dividend
27 Dec 2019 Last Split
- IPO Date

Overview

JW Pharmaceutical Corporation is a distinguished entity in the pharmaceutical industry, with its roots deeply planted in Gwacheon-si, South Korea since its establishment in 1945. The company has made significant strides not only domestically but also on the international stage, dedicating itself to the manufacturing and distribution of a wide array of medicines and medical supplies. Its expansive product portfolio addresses critical health areas such as cancer, immunological and cardiovascular diseases, regenerative medicine, eye disorders, and more, demonstrating its commitment to improving healthcare outcomes globally.

Products and Services

  • Cancer, Immunological Disease, and Pancreatic Cancer Products:

    JW Pharmaceutical Corporation offers a range of medicines specifically designed for the treatment of various types of cancer, immunological diseases, and particularly pancreatic cancer. These products are a testament to the company’s commitment to providing solutions that significantly improve patient care in these challenging health areas.

  • Cardiovascular System and Metabolic Diseases Medications:

    The company provides a variety of medications aimed at addressing ailments related to the cardiovascular system and metabolic diseases, offering patients across the globe hope and improved quality of life through innovative treatment options.

  • Regenerative Medicine and Eye Diseases Solutions:

    In the cutting-edge field of regenerative medicine and eye disease treatments, JW Pharmaceutical Corporation is at the forefront, developing therapies that offer new possibilities for recovery and management of previously untreatable conditions.

  • Infant Care System and Gynecological Examining Table:

    Besides pharmaceuticals, the company extends its expertise to the production of medical equipment such as infant care systems and gynecological examining tables, highlighting its versatility and dedication to enhancing healthcare experiences from birth and beyond.

  • Operating Room Equipment and Steam Sterilizer:

    Understanding the critical nature of sterility and efficiency in operating rooms, JW Pharmaceutical Corporation offers high-quality operating room equipment and steam sterilizers, ensuring that medical facilities can maintain the highest standards of patient care and safety.

  • Wound Care, Pain Care, and Beauty Care Related Products:

    The company’s portfolio also includes a diverse range of products for wound care, pain management, and beauty care, addressing a comprehensive spectrum of consumer health needs with advanced solutions that promote healing, comfort, and well-being.

Contact Information

Address: JW Gwacheon Tower, 38, Gwacheon-si, South Korea, 13840
Phone: 82 2 8406 777